Correlation Between Kiromic Biopharma and LMF Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kiromic Biopharma and LMF Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiromic Biopharma and LMF Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiromic Biopharma and LMF Acquisition Opportunities, you can compare the effects of market volatilities on Kiromic Biopharma and LMF Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiromic Biopharma with a short position of LMF Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiromic Biopharma and LMF Acquisition.

Diversification Opportunities for Kiromic Biopharma and LMF Acquisition

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Kiromic and LMF is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Kiromic Biopharma and LMF Acquisition Opportunities in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LMF Acquisition Oppo and Kiromic Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiromic Biopharma are associated (or correlated) with LMF Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LMF Acquisition Oppo has no effect on the direction of Kiromic Biopharma i.e., Kiromic Biopharma and LMF Acquisition go up and down completely randomly.

Pair Corralation between Kiromic Biopharma and LMF Acquisition

If you would invest  268.00  in Kiromic Biopharma on August 31, 2024 and sell it today you would earn a total of  0.00  from holding Kiromic Biopharma or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy0.79%
ValuesDaily Returns

Kiromic Biopharma  vs.  LMF Acquisition Opportunities

 Performance 
       Timeline  
Kiromic Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kiromic Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Kiromic Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
LMF Acquisition Oppo 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days LMF Acquisition Opportunities has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Kiromic Biopharma and LMF Acquisition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kiromic Biopharma and LMF Acquisition

The main advantage of trading using opposite Kiromic Biopharma and LMF Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiromic Biopharma position performs unexpectedly, LMF Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LMF Acquisition will offset losses from the drop in LMF Acquisition's long position.
The idea behind Kiromic Biopharma and LMF Acquisition Opportunities pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency